Sören Dahlke1, Diana Steinmann2, Hans Christiansen2, Martin Durisin3, Andre Eckardt4, Gerd Wegener5, Michael Bremer2, Andreas Meyer2. 1. Department of Radiation Oncology, Medical School Hannover, Hannover, Germany Dahlke.Soeren@gmx.de. 2. Department of Radiation Oncology, Medical School Hannover, Hannover, Germany. 3. Department of Otolaryngology, Medical School Hannover, Hannover, Germany. 4. Department of Cranio-Maxillo-Facial Surgery, Medical School Hannover, Hannover, Germany. 5. Tumour Centre Hannover, Medical School Hannover, Hannover, Germany.
Abstract
AIM: To evaluate treatment-related factors such as overall treatment time (OTT) and radiation treatment time (RTT) in head-and-neck cancer. PATIENTS AND METHODS: A total of 216 patients with locoregionally advanced inoperable head and neck cancer were treated with definitive radio(chemo)therapy. Mean follow-up was 37 months. RESULTS: Median time from diagnosis to start of radiotherapy (total waiting time) was 34 days, and comprised of referral waiting time and time for preparatory work. Median RTT was 40 days, and median OTT was 91 days. At 6, 12 and 24 months local recurrence-free survival (LRFS) was 75%, 65% and 60%; metastasis-free survival (MFS) was 84%, 77% and 70%; overall survival (OS) was 72%, 58% and 40%. Tumor stage, boost and chemotherapy were significant for OS, waiting time for preparatory work and RTT were significant for MFS, and referral waiting time and total radiotherapy dose for LRFS. CONCLUSION: RTT ≤40 days was a prognostic factor for better MFS. Prolonged waiting time had a converse effect for radiotherapy with better outcome on MFS and LRFS. Copyright
AIM: To evaluate treatment-related factors such as overall treatment time (OTT) and radiation treatment time (RTT) in head-and-neck cancer. PATIENTS AND METHODS: A total of 216 patients with locoregionally advanced inoperable head and neck cancer were treated with definitive radio(chemo)therapy. Mean follow-up was 37 months. RESULTS: Median time from diagnosis to start of radiotherapy (total waiting time) was 34 days, and comprised of referral waiting time and time for preparatory work. Median RTT was 40 days, and median OTT was 91 days. At 6, 12 and 24 months local recurrence-free survival (LRFS) was 75%, 65% and 60%; metastasis-free survival (MFS) was 84%, 77% and 70%; overall survival (OS) was 72%, 58% and 40%. Tumor stage, boost and chemotherapy were significant for OS, waiting time for preparatory work and RTT were significant for MFS, and referral waiting time and total radiotherapy dose for LRFS. CONCLUSION: RTT ≤40 days was a prognostic factor for better MFS. Prolonged waiting time had a converse effect for radiotherapy with better outcome on MFS and LRFS. Copyright
Authors: David J Sher; Marshall R Posner; Roy B Tishler; Nicholas J Sarlis; Robert I Haddad; Edward J Holupka; Phillip M Devlin Journal: Int J Radiat Oncol Biol Phys Date: 2011-02-06 Impact factor: 7.038
Authors: Donald M Cannon; Heather M Geye; Gregory K Hartig; Anne M Traynor; Tien Hoang; Timothy M McCulloch; Peggy A Wiederholt; Richard J Chappell; Paul M Harari Journal: Head Neck Date: 2013-11-27 Impact factor: 3.147
Authors: Michel C van Harten; Frank J P Hoebers; Kenneth W Kross; Erik D van Werkhoven; Michiel W M van den Brekel; Boukje A C van Dijk Journal: Oral Oncol Date: 2014-12-22 Impact factor: 5.337
Authors: Deborah T Blumenthal; Minhee Won; Minesh P Mehta; Walter J Curran; Luis Souhami; Jeff M Michalski; C Leland Rogers; Benjamin W Corn Journal: J Clin Oncol Date: 2008-12-29 Impact factor: 44.544
Authors: Wouter T C Bots; Sven van den Bosch; Ellen M Zwijnenburg; Tim Dijkema; Guido B van den Broek; Willem L J Weijs; Lia C G Verhoef; Johannes H A M Kaanders Journal: Head Neck Date: 2017-03-06 Impact factor: 3.147